not present
Method | Procedure / Supply Codes | ICD-10 | Description |
Oral Contraceptives | E/M /S4993 | Z30.011 | Initiate OC |
Oral Contraceptives | E/M /S4993 | Z30.41 | Surveillance of OC (Includes refills) |
Depo Provera | E/M / injection / J1050 | Z30.13 | Initial prescription of injectable contr ... |
Depo Provera | E/M / injection / J1050 | Z30.42 | Surveillance of injectable contraceptive ... |
Full Answer
· ICD-10 Depo Provera. Thread starter JCampbell; Start date Aug 3, 2015; J. JCampbell Guru. Messages 165 Location Chester, IL Best answers 0. Aug 3, 2015 #1 Can anyone tell me what ICD-10 code you would when a patient comes in for a depo provera injection? Thanks, Jennifer . S. sarame Guest. Messages 28 Location Lancaster County Best answers 0 ...
· Z30.42 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z30.42 became effective on October 1, 2021. This is the American ICD-10-CM version of Z30.42 - other international versions of ICD-10 Z30.42 may differ.
· Z79.3 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z79.3 became effective on October 1, 2021. This is the American ICD-10-CM version of Z79.3 - other international versions of ICD-10 Z79.3 may differ.
24 rows · ICD-10 CM Codes Method Procedure / Supply Codes ICD-10 Description Oral Contraceptives ...
Encounter for surveillance of injectable contraceptive 1 Z30.42 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 2 The 2021 edition of ICD-10-CM Z30.42 became effective on October 1, 2020. 3 This is the American ICD-10-CM version of Z30.42 - other international versions of ICD-10 Z30.42 may differ.
Encounter for surveillance of injectable contraceptive 1 Injectable contraceptive management 2 Surveillance of depot contraception done 3 Surveillance of injectable contraceptive done
The Drug Listing Act of 1972 requires registered drug establishments to provide the Food and Drug Administration (FDA) with a current list of all drugs manufactured, prepared, propagated, compounded, or processed by it for commercial distribution. (See Section 510 of the Federal Food, Drug, and Cosmetic Act (Act) (21 U.S.C. § 360)).
Each listed drug product is assigned a unique 10-digit, 3-segment number †. This number, known as the NDC, identifies the labeler, product, and trade package size.
Assignment of an NDC number does not in any way denote FDA approval of the product. Any representation that creates an impression of official approval because of possession of an NDC number is misleading and constitutes misbranding. (21 CFR 207.39)